Plant-Based Investment Corp

Healthcare US CWWBF

0.0USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

52 Week Range

LowHigh

Fundamentals

Previous Close -
Market Cap0.00031M
Volume0
P/E Ratio-
Dividend Yield-%
Revenue TTM-16.08588M
Revenue Per Share TTM-0.585
Gross Profit TTM -16.08588M
Diluted EPS TTM-0.61

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2021-10-31	2020-10-31	2019-10-31	2018-10-31
Type	yearly	yearly	yearly	yearly
Date	2021-10-31	2020-10-31	2019-10-31	2018-10-31
Income before tax	-7.79042M	-14.65322M	-2.82557M	3.48M
Minority interest	-	-	-	0.00000M
Net income	-7.79042M	-14.59447M	-2.88103M	3.48M
Selling general administrative	2.73M	1.61M	1.66M	0.84M
Selling and marketing expenses	-	-	-	-
Gross profit	-	-	-1.52026M	4.32M
Reconciled depreciation	-	-	-	-
Ebit	-5.18869M	-14.64971M	-2.82557M	3.35M
Ebitda	-	-	-	-
Depreciation and amortization	-	-	-	-
Non operating income net other	-	-	-	0.00000M
Operating income	-	-	-3.49574M	3.48M
Other operating expenses	-	-	-	0.00000M
Interest expense	0.00000M	0.00000M	0.00000M	0.00000M
Tax provision	0.00000M	-0.05875M	0.06M	0.00329M
Interest income	0.42M	3.15M	0.44M	0.21M
Net interest income	0.42M	3.15M	0.44M	0.21M
Extraordinary items	-	-	-	0.00000M
Non recurring	-	-	-	0.00000M
Other items	-	-	-	0.00000M
Income tax expense	-	-0.05875M	0.06M	0.00329M
Total revenue	-3.53826M	-12.70622M	-1.16156M	6.11M
Total operating expenses	-	-	1.66M	2.87M
Cost of revenue	-	-	-	2.03M
Total other income expense net	-	-	0.67M	-0.00004M
Discontinued operations	-	-	-	0.00000M
Net income from continuing ops	-7.79042M	-14.59447M	-2.88103M	3.48M
Net income applicable to common shares	-7.79042M	-14.59447M	-2.88103M	3.48M
Preferred stock and other adjustments	-	-	-	0.00000M

Breakdown	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31
Total assets	24.59M	31.12M	39.81M	42.22M	0.00000M
Intangible assets	-	-	-	0.00000M	0.00000M
Earning assets	-	-	-	-	-
Other current assets	0.21M	-	-	0.67M	0.00000M
Total liab	2.05M	0.38M	0.38M	0.75M	0.00000M
Total stockholder equity	22.53M	30.74M	39.43M	41.47M	0.00000M
Deferred long term liab	-	-	-	0.00000M	0.00000M
Other current liab	-	-	0.04M	0.00329M	0.00000M
Common stock	33.68M	33.75M	28.19M	27.52M	0.00000M
Capital stock	33.68M	33.75M	28.19M	27.52M	-
Retained earnings	-21.95629M	-13.81920M	0.78M	3.48M	0.00000M
Other liab	1.04M	-	-	0.00000M	0.00000M
Good will	-	-	-	0.00000M	0.00000M
Other assets	-	-	-	0.17M	0.00000M
Cash	0.16M	0.18M	0.26M	0.11M	0.00000M
Cash and equivalents	-	-	-	-	-
Total current liabilities	1.01M	0.38M	0.38M	0.75M	0.00000M
Current deferred revenue	-	-	-	-	-
Net debt	-	-	-	0.24M	-
Short term debt	-	-	-	0.00000M	0.00000M
Short long term debt	-	-	-	0.35M	0.00000M
Short long term debt total	-	-	-	-	0.00000M
Other stockholder equity	-	-	7.89M	7.89M	0.00000M
Property plant equipment	-	-	-	0.00000M	0.00000M
Total current assets	2.10M	0.59M	0.54M	42.22M	0.00000M
Long term investments	22.48M	30.53M	39.27M	41.35M	0.00000M
Net tangible assets	22.53M	30.74M	39.43M	41.47M	0.00000M
Short term investments	-	-	39.27M	41.35M	0.00000M
Net receivables	1.66M	0.34M	0.27M	0.06M	0.00000M
Long term debt	-	-	-	0.00000M	0.00000M
Inventory	-	-	-	0.00000M	0.00000M
Accounts payable	0.71M	0.23M	0.15M	0.26M	0.00000M
Total permanent equity	-	-	-	0.00000M	0.00000M
Noncontrolling interest in consolidated entity	-	-	-	0.00000M	0.00000M
Temporary equity redeemable noncontrolling interests	-	-	-	0.00000M	0.00000M
Accumulated other comprehensive income	-	-	-	0.00000M	0.00000M
Additional paid in capital	-	-	-	0.00000M	0.00000M
Common stock total equity	-	-	-	0.00000M	0.00000M
Preferred stock total equity	-	-	-	0.00000M	0.00000M
Retained earnings total equity	-	-	-	0.00000M	0.00000M
Treasury stock	-	-	-	0.00000M	0.00000M
Accumulated amortization	-	-	-	0.00000M	0.00000M
Non currrent assets other	-	-	-	0.00000M	0.00000M
Deferred long term asset charges	-	-	-	0.00000M	0.00000M
Non current assets total	-	-	-	0.00000M	0.00000M
Capital lease obligations	-	-	-	0.00000M	0.00000M
Long term debt total	-	-	-	0.00000M	0.00000M

Breakdown	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31
Investments	-	-	-	0.00000M	0.00000M
Change to liabilities	0.53M	0.11M	-0.06573M	0.40M	0.00000M
Total cashflows from investing activities	-	-	-	0.00000M	0.00000M
Net borrowings	0.10M	0.10M	-0.35356M	0.35M	0.00000M
Total cash from financing activities	2.04M	2.04M	-0.76189M	36.30M	0.00000M
Change to operating activities	0.61M	1.07M	2.73M	-35.14792M	0.00000M
Net income	-7.79042M	-14.59447M	-2.88103M	3.48M	0.00000M
Change in cash	-0.01566M	-0.07916M	0.15M	0.11M	0.00000M
Begin period cash flow	0.18M	0.26M	0.11M	0.00000M	0.00000M
End period cash flow	0.16M	0.18M	0.26M	0.11M	0.00000M
Total cash from operating activities	-2.05081M	-0.07916M	0.91M	-36.18730M	0.00000M
Issuance of capital stock	1.97M	-	-	30.08M	-
Depreciation	-	-	-	0.00000M	0.00000M
Other cashflows from investing activities	-	-	-	0.00000M	0.00000M
Dividends paid	-	-	-	0.00000M	0.00000M
Change to inventory	-	-	-	0.00000M	0.00000M
Change to account receivables	-0.28940M	-0.27986M	-0.20399M	-0.56363M	0.00000M
Sale purchase of stock	-	0.00000M	-0.40602M	0.00000M	0.00000M
Other cashflows from financing activities	-0.04096M	-0.04096M	-0.00257M	5.86M	0.00000M
Change to netincome	4.82M	13.72M	1.29M	-4.35795M	0.00000M
Capital expenditures	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Change receivables	-	-	-	0.00000M	0.00000M
Cash flows other operating	-	-	-	0.00000M	0.00000M
Exchange rate changes	-	-	-	0.00000M	0.00000M
Cash and cash equivalents changes	-	-	-	0.00000M	0.00000M
Change in working capital	-2.63603M	-0.54897M	-0.04749M	-0.35601M	0.00000M
Stock based compensation	-	-	-	-	-
Other non cash items	2.91M	-2.03420M	-0.67018M	1.69M	-
Free cash flow	-2.05081M	-0.07916M	0.91M	-36.18730M	-

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
CWWBF Plant-Based Investment Corp	- -%	-	-	-	0.65	-	1.17	-1.0036
ZTS Zoetis Inc	-2.82 3.58%	75.89	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	-0.19 0.62%	30.56	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	157.12	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	- -%	42.94	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

Plant-Based Investment Corp. is no longer investing. It is a principal investment firm. The firm seeks to invest in cannabis industry. It also invests in public cannabis companies. The firm employs fundamental analysis along with a combination of bottom-up and top-down stock picking approach to create its portfolios. Cannabis Growth Opportunity Corporation is based in Toronto, Canada.

Plant-Based Investment Corp

240 Richmond Street West, Toronto, ON, Canada, M5V 1V6

647-660-0566
https://www.pbinvest.ca

Key Executives

Name	Title	Year Born
Mr. Michael D. Johnston C.A., CPA, CA, CPA	CFO, Corp. Sec. & Director	1981
Mr. Michael Bruce Campbell C.A.I.A., C.F.A., CFA	Public Markets Portfolio Mang.	1971
Mr. Sean Conacher	Chief Strategy Officer & Director	1970
Mr. Paul Jason Crath	CEO, Gen. Counsel, VP of Corp. Devel. & Director	1970
Mr. Michael D. Johnston C.A., CPA	CFO, Corporate Secretary & Director	1981
Mr. Paul Jason Crath J.D.	CEO, General Counsel, VP of Corporate Development & Director	1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.